{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:43:03Z","timestamp":1782301383442,"version":"3.54.5"},"reference-count":37,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Kidney J"],"DOI":"10.1093\/ckj\/sfw106","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T01:20:18Z","timestamp":1481678418000},"page":"sfw106","source":"Crossref","is-referenced-by-count":19,"title":["B cell\u2013depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis"],"prefix":"10.1093","author":[{"given":"Sigrid","family":"Lundberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Westergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Smolander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,12,13]]},"reference":[{"key":"2016121317200905000_sfw106v1.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"2016121317200905000_sfw106v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2012.280"},{"key":"2016121317200905000_sfw106v1.3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00467-013-2550-4","article-title":"Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schonlein purpura nephritis","volume":"28","author":"Davin","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"2016121317200905000_sfw106v1.4","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000013883.99976.22"},{"key":"2016121317200905000_sfw106v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.59"},{"key":"2016121317200905000_sfw106v1.6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008070786"},{"key":"2016121317200905000_sfw106v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft312"},{"key":"2016121317200905000_sfw106v1.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.27.9836"},{"key":"2016121317200905000_sfw106v1.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1308488"},{"key":"2016121317200905000_sfw106v1.10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2169\/internalmedicine.52.9325","article-title":"Rituximab treatment for adult purpura nephritis with nephrotic syndrome","volume":"52","author":"Ishiguro","year":"2013","journal-title":"Intern Med"},{"key":"2016121317200905000_sfw106v1.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr137"},{"key":"2016121317200905000_sfw106v1.12","doi-asserted-by":"crossref","first-page":"619218","DOI":"10.1155\/2014\/619218","article-title":"Successful outcome of a corticodependent Henoch-Schonlein purpura adult with rituximab","volume":"2014","author":"Pindi Sala","year":"2014","journal-title":"Case Report Med"},{"key":"2016121317200905000_sfw106v1.13","doi-asserted-by":"publisher","DOI":"10.1159\/000319656"},{"key":"2016121317200905000_sfw106v1.14","doi-asserted-by":"crossref","unstructured":"Chancharoenthana W , Townamchai N , Leelahavanichkul A et al . Rituximab for recurrent IgA nephropathy in kidney transplantation: a report of 3 cases and proposed mechanisms. Nephrology (Carlton) 2016; doi:10.1111\/nep.12722","DOI":"10.1111\/nep.12722"},{"key":"2016121317200905000_sfw106v1.15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2016121317200905000_sfw106v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.243"},{"key":"2016121317200905000_sfw106v1.17","first-page":"CD003965","article-title":"Immunosuppressive agents for treating IgA nephropathy","volume":"8","author":"Vecchio","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2016121317200905000_sfw106v1.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-6686.2013.12007.x"},{"key":"2016121317200905000_sfw106v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.12.049"},{"key":"2016121317200905000_sfw106v1.20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002231"},{"key":"2016121317200905000_sfw106v1.21","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05080610"},{"key":"2016121317200905000_sfw106v1.22","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-88"},{"key":"2016121317200905000_sfw106v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.27524"},{"key":"2016121317200905000_sfw106v1.24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151522"},{"key":"2016121317200905000_sfw106v1.25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr052"},{"key":"2016121317200905000_sfw106v1.26","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-014-0165-x"},{"key":"2016121317200905000_sfw106v1.27","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012101017"},{"key":"2016121317200905000_sfw106v1.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1415463"},{"key":"2016121317200905000_sfw106v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.150"},{"key":"2016121317200905000_sfw106v1.30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/07853890.2016.1153805","article-title":"The effects of cytotoxic therapy in progressive IgA nephropathy","volume":"48","author":"Shin","year":"2016","journal-title":"Ann Med"},{"key":"2016121317200905000_sfw106v1.31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2003.00030.x"},{"issue":"(Suppl 2)","key":"2016121317200905000_sfw106v1.32","first-page":"55","article-title":"Plasma exchange in progressive primary IgA nephropathy","volume":"8","author":"Coppo","year":"1985","journal-title":"Int J Artif Organs"},{"key":"2016121317200905000_sfw106v1.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-007-0498-y"},{"key":"2016121317200905000_sfw106v1.34","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.02.178"},{"key":"2016121317200905000_sfw106v1.35","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv008"},{"key":"2016121317200905000_sfw106v1.36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00467-014-2954-9","article-title":"The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy","volume":"30","author":"Coppo","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"2016121317200905000_sfw106v1.37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/nep.12527","article-title":"Emerging therapies in immunoglobulin A nephropathy","volume":"20","author":"Yeo","year":"2015","journal-title":"Nephrology (Carlton)"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/10\/1\/20\/17690967\/sfw106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:45:49Z","timestamp":1503621949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article-lookup\/doi\/10.1093\/ckj\/sfw106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,13]]},"references-count":37,"alternative-id":["10.1093\/ckj\/sfw106"],"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfw106","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,13]]}}}